Related references
Note: Only part of the references are listed.The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice
Natalia Nowicka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy
Xiang Wang et al.
ACTA PHARMACOLOGICA SINICA (2021)
Emerging role of S100B protein implication in Parkinson's disease pathogenesis
Efthalia Angelopoulou et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Amelioration of human peritoneal mesothelial cell co-culture-evoked malignant potential of ovarian cancer cells by acacetin involves LPA release-activated RAGE-PI3K/AKT signaling
Meng Tian et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2021)
Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity
Peng Zhang et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways
Hany H. Arab et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Thymoma pathology and myasthenia gravis outcomes
Deepak Menon et al.
MUSCLE & NERVE (2021)
Hyperglycemia induces RAGE-dependent hippocampal spatial memory impairments
Zeinab Momeni et al.
PHYSIOLOGY & BEHAVIOR (2021)
Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice
Michaele B. Manigrasso et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
The receptor for advanced glycation endproducts (RAGE) decreases survival of tumor-bearing mice by enhancing the generation of lung metastasis-associated myeloid-derived suppressor cells
Tanna Wuren et al.
CELLULAR IMMUNOLOGY (2021)
Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
Agnieszka Nowak et al.
CELLS (2021)
被撤回的出版物: Combined rs-fMRI study on brain functional imaging and mechanism of RAGE-DAMPs of depression: Evidence from MDD patients to chronic stress-induced depression models in cynomolgus monkeys and mice (Retracted article. See vol. 12, 2022)
Weixin Yan et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Transthyretin and Receptor for Advanced Glycation End Product's Differential Levels Associated with the Pathogenesis of Rheumatoid Arthritis
Monu et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy
Lu Zhang et al.
CELL DEATH & DISEASE (2021)
The cross-talk between RAGE and DIAPH1 in neurological complications of diabetes: A review
Kamila Zglejc-Waszak et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?
Timothy N. Perkins et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2021)
Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment
Suzanne Ostrand-Rosenberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
S100 proteins in atherosclerosis
Xuan Xiao et al.
CLINICA CHIMICA ACTA (2020)
Compromised DNA repair is responsible for diabetes-associated fibrosis
Varun Kumar et al.
EMBO JOURNAL (2020)
Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
Ali H. El-Far et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
RAGE Silencing Ameliorates Neuroinflammation by Inhibition of p38-NF-κB Signaling Pathway in Mouse Model of Parkinson's Disease
Xiaoli Wang et al.
FRONTIERS IN NEUROSCIENCE (2020)
Advanced glycation end products in diabetes, cancer and phytochemical therapy
Begum Dariya et al.
DRUG DISCOVERY TODAY (2020)
Roles for lysophosphatidic acid signaling in vascular development and disease
Susan S. Smyth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
Role of S100 proteins in health and disease
Laura L. Gonzalez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology
Man Sup Kwak et al.
FRONTIERS IN IMMUNOLOGY (2020)
Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy
Jena J. Steinle
CELLULAR SIGNALLING (2020)
RAGE and its ligands: from pathogenesis to therapeutics
Nitish Jangde et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro
Bo Ding et al.
JOURNAL OF NEUROINFLAMMATION (2020)
RAGE Signaling in Melanoma Tumors
Olamide T. Olaoba et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment
Rashmi Ray et al.
CELL COMMUNICATION AND SIGNALING (2020)
Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis
Caijun Zha et al.
CANCER BIOLOGY & MEDICINE (2020)
Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model
Soo Jeong Kim et al.
LABORATORY INVESTIGATION (2019)
Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non-small cell lung cancer cells via the HMGB1/RAGE axis and the NF-κB/STAT3 pathway
Qiongqiong Liu et al.
ONCOLOGY REPORTS (2019)
S100 Proteins in Alzheimer's Disease
Joana S. Cristovao et al.
FRONTIERS IN NEUROSCIENCE (2019)
Lysophosphatidic Acid Signaling in Diabetic Nephropathy
Jong Han Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Metabolic Signature of Macrophage Responses
Antonella Viola et al.
FRONTIERS IN IMMUNOLOGY (2019)
Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease
Nordin M. J. Hanssen et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2019)
The receptor for advanced glycation end products (RAGE) and DIAPH1: unique mechanisms and healing the wounded vascular system
Ravichandran Ramasamy et al.
EXPERT REVIEW OF PROTEOMICS (2019)
HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development
Fei Qian et al.
MOLECULAR CARCINOGENESIS (2019)
Targeting RAGE Signaling in Inflammatory Disease
Barry I. Hudson et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer's Disease
Kedar Batkulwar et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability
Xiaoyan Zhou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy
A. Tammaro et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-beta and Increasing Resistance to Apoptosis
Shinji Hagiwara et al.
DIABETES (2018)
High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice
Xiaodong Ge et al.
HEPATOLOGY (2018)
RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity
Fang Fang et al.
HUMAN MOLECULAR GENETICS (2018)
Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer's Disease
Julia Derk et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology
Michael K. Hehir et al.
NEUROLOGIC CLINICS (2018)
Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain
Hiroshi Ueda et al.
PAIN (2018)
S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
Md. Imran Khan et al.
PLOS ONE (2018)
Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein
Revansiddha Katte et al.
PLOS ONE (2018)
The receptor for advanced glycation end products: A fuel to pancreatic cancer
Uzma Shahab et al.
SEMINARS IN CANCER BIOLOGY (2018)
RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review
Gowri Palanissami et al.
HORMONES & CANCER (2018)
Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention
Lu-yao Ao et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2018)
Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease
A. H. Burstein et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2018)
Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney
Michaele B. Manigrasso et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Inhibition of the Receptor for Advanced Glycation End-Products (RAGE) Attenuates Neuroinflammation While Sensitizing Cortical Neurons Towards Death in Experimental Subarachnoid Hemorrhage
Hua Li et al.
MOLECULAR NEUROBIOLOGY (2017)
Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis
T. Kwak et al.
ONCOGENE (2017)
RAGE-Specific Inhibitor FPS-ZM1 Attenuates AGEs-Induced Neuroinflammation and Oxidative Stress in Rat Primary Microglia
Chao Shen et al.
NEUROCHEMICAL RESEARCH (2017)
Homeostatic nuclear RAGE-ATM interaction is essential for efficient DNA repair
Varun Kumar et al.
NUCLEIC ACIDS RESEARCH (2017)
Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases
Kyunghee Byun et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients
M. Bouchikh et al.
REVUE NEUROLOGIQUE (2017)
Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis
Valeria Bortolotto et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Amyloidogenic medin induces endothelial dysfunction and vascular inflammation through the receptor for advanced glycation endproducts
Raymond Q. Migrino et al.
CARDIOVASCULAR RESEARCH (2017)
Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone
Mikhail G. Kolonin et al.
CANCER RESEARCH (2017)
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
Hugo Vicente Miranda et al.
BRAIN (2017)
Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways
Christos Adamopoulos et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
High-mobility group box 1 in multiple sclerosis
Zohara Sternberg et al.
IMMUNOLOGIC RESEARCH (2016)
Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease
Tatsuya Sasaki et al.
EXPERIMENTAL NEUROLOGY (2016)
Roles of LPA receptor signaling in breast cancer
Jizhao Wang et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progression
Zohara Sternberg et al.
IMMUNOBIOLOGY (2016)
Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease
Niki L. Reynaert et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Hyperglycemia in Stroke Impairs Polarization of Monocytes/Macrophages to a Protective Noninflammatory Cell Type
Mahtab A. Khan et al.
JOURNAL OF NEUROSCIENCE (2016)
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
Matteo Santoro et al.
NEUROBIOLOGY OF DISEASE (2016)
Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling
Jing Xue et al.
STRUCTURE (2016)
The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins
Laure Yatime et al.
STRUCTURE (2016)
Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction
Michaele B. Manigrasso et al.
SCIENTIFIC REPORTS (2016)
Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis
Carlos Machahua et al.
RESPIRATORY RESEARCH (2016)
Diabetes mellitus and cognitive impairments
Elham Saedi et al.
WORLD JOURNAL OF DIABETES (2016)
HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells
Meichu Cheng et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Linking RAGE and Nox in diabetic micro- and macrovascular complications
C. Koulis et al.
DIABETES & METABOLISM (2015)
Recent advances in detection of AGEs: Immunochemical, bioanalytical and biochemical approaches
Jalaluddin Mohd. Ashraf et al.
IUBMB LIFE (2015)
Receptor for Advanced Glycation End-Product Antagonist Reduces Blood-Brain Barrier Damage After Intracerebral Hemorrhage
Fan Yang et al.
STROKE (2015)
An Apoptotic 'Eat Me' Signal: Phosphatidylserine Exposure
Katsumori Segawa et al.
TRENDS IN CELL BIOLOGY (2015)
Emerging and novel functions of complement protein C1 q
Lubna Kouser et al.
FRONTIERS IN IMMUNOLOGY (2015)
TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity
Gordon J. Freeman et al.
IMMUNOLOGICAL REVIEWS (2015)
JB Special Review-Recent Progress in Lipid Mediators Lysophosphatidic acid as a lipid mediator with multiple biological actions
Shizu Aikawa et al.
JOURNAL OF BIOCHEMISTRY (2015)
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Kerstin Nowotny et al.
BIOMOLECULES (2015)
Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis
Ying-Hsien Kao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE)
Sandhya G. Rani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)
Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage
Hua Li et al.
BRAIN RESEARCH (2014)
Role of AGEs-RAGE System in Cardiovascular Disease
Kei Fukami et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway
Xu Wang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)
Thematic Review Series: Lysophospholipids and their Receptors LPA receptor signaling: pharmacology, physiology, and pathophysiology
Yun C. Yung et al.
JOURNAL OF LIPID RESEARCH (2014)
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis
Zohara Sternberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Association of RAGE gene polymorphisms with sporadic Parkinson's disease in Chinese Han population
Jing Gao et al.
NEUROSCIENCE LETTERS (2014)
Expression of RAGE and HMGB1 in Thymic Epithelial Tumors, Thymic Hyperplasia and Regular Thymic Morphology
Bernhard Moser et al.
PLOS ONE (2014)
Structural Insights into Calcium-Bound S100P and the V Domain of the RAGE Complex
Srinivasa R. Penumutchu et al.
PLOS ONE (2014)
Unlocking the biology of RAGE in diabetic microvascular complications
Michaele B. Manigrasso et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
R. Kang et al.
CELL DEATH & DISEASE (2014)
Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury
Hongju Zhang et al.
CELL DEATH & DISEASE (2014)
Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease
Bo-Ryoung Choi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients
Francesco Piarulli et al.
ATHEROSCLEROSIS (2013)
Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE)
Sepuru K. Mohan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang et al.
CELL (2013)
Functions of S100 Proteins
R. Donato et al.
CURRENT MOLECULAR MEDICINE (2013)
Advanced glycation endproducts in food and their effects on health
Malene W. Poulsen et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson's Disease
Erika Guerrero et al.
MOLECULAR NEUROBIOLOGY (2013)
Increased expression of the receptor for advanced glycation end-products in human peripheral neuropathies
Judyta K. Juranek et al.
BRAIN AND BEHAVIOR (2013)
The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis
Bernhard Moser et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
Kinnari Sathe et al.
BRAIN (2012)
RAGE binds C1q and enhances C1q-mediated phagocytosis
Wanchao Ma et al.
CELLULAR IMMUNOLOGY (2012)
Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction Pathways
Fatouma Toure et al.
CIRCULATION RESEARCH (2012)
Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1
Vivek Rai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling
Vivek Rai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site
Andres Nieto-Posadas et al.
NATURE CHEMICAL BIOLOGY (2012)
Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling
Sung Min Son et al.
NEUROBIOLOGY OF AGING (2012)
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
Peter Teismann et al.
NEUROBIOLOGY OF AGING (2012)
AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation
Xiao-Hong Li et al.
NEUROBIOLOGY OF AGING (2012)
Amyloid Beta Induces Oxidative Stress-Mediated Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy
Anna Carrano et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease
Anton Rahmadi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms
Lili Mu et al.
CLINICAL IMMUNOLOGY (2011)
Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells
Mei He et al.
EMBO REPORTS (2011)
Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transition
Jeong Sup Song et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2PP2A/SET
Lisette Arnaud et al.
FEBS LETTERS (2011)
Participation of the Receptor for Advanced Glycation End Products in Efferocytosis
Arnaud Friggeri et al.
JOURNAL OF IMMUNOLOGY (2011)
High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus
V. Urbonaviciute et al.
JOURNAL OF INTERNAL MEDICINE (2011)
C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation
Boon King Teh et al.
MOLECULAR IMMUNOLOGY (2011)
A functional p.82G>S polymorphism in the RAGE gene is associated with multiple sclerosis in the Chinese population
Keshen Li et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Velandai Srikanth et al.
NEUROBIOLOGY OF AGING (2011)
ROLE OF Aβ-RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS INTERACTION IN OXIDATIVE STRESS AND CYTOSOLIC PHOSPHOLIPASE A2 ACTIVATION IN ASTROCYTES AND CEREBRAL ENDOTHELIAL CELLS
S. Askarova et al.
NEUROSCIENCE (2011)
TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding
Masakiyo Sakaguchi et al.
PLOS ONE (2011)
RAGE: a single receptor fits multiple ligands
Guenter Fritz
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Nε-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model
Yeong-Gon Choi et al.
BIOCHIMIE (2010)
Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
Anastasia Z. Kalea et al.
CANCER RESEARCH (2010)
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
R. Kang et al.
CELL DEATH AND DIFFERENTIATION (2010)
S100B Interaction With the Receptor for Advanced Glycation End Products (RAGE) A Novel Receptor-Mediated Mechanism for Myocyte Apoptosis Postinfarction
J. N. Tsoporis et al.
CIRCULATION RESEARCH (2010)
RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease
Fang Fang et al.
FASEB JOURNAL (2010)
Direct interaction between CD91 and C1q
Karen Duus et al.
FEBS JOURNAL (2010)
Natural and amyloid self-assembly of S100 proteins: structural basis of functional diversity
Gunter Fritz et al.
FEBS JOURNAL (2010)
Autotaxin-an LPA producing enzyme with diverse functions
Keita Nakanaga et al.
JOURNAL OF BIOCHEMISTRY (2010)
Microglial Receptor for Advanced Glycation End Product-Dependent Signal Pathway Drives β-Amyloid-Induced Synaptic Depression and Long-Term Depression Impairment in Entorhinal Cortex
Nicola Origlia et al.
JOURNAL OF NEUROSCIENCE (2010)
Dietary Advanced Glycation End Products and Aging
Claudia Luevano-Contreras et al.
NUTRIENTS (2010)
A look inside the diabetic brain: Contributors to diabetes-induced brain aging
Shayna A. Wrighten et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Binding of S100 proteins to RAGE: An update
Estelle Leclerc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
RAGE: a novel biological and genetic marker for vascular disease
Anastasia Z. Kalea et al.
CLINICAL SCIENCE (2009)
RAGE Gene Polymorphisms in Patients with Multiple Sclerosis
Zoltan Tiszlavicz et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2009)
HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses
Hideyuki Yanai et al.
NATURE (2009)
Two pathways for lysophosphatidic acid production
Junken Aoki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
Aino Soro-Paavonen et al.
DIABETES (2008)
Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE)
Jingjing Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
Asa Andersson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Site-specific blockade of RAGE-Vd prevents amyloid-β oligomer neurotoxicity
Emmanuel Sturchler et al.
JOURNAL OF NEUROSCIENCE (2008)
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
Sajjad Muhammad et al.
JOURNAL OF NEUROSCIENCE (2008)
Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity
Z. Sternberg et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms
Gong-Ping Liu et al.
NEUROBIOLOGY OF AGING (2008)
Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor
S-Y Park et al.
CELL DEATH AND DIFFERENTIATION (2008)
BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module
Daeho Park et al.
NATURE (2007)
Structural and functional insights into RAGE activation by multimeric S100B
Thorsten Ostendorp et al.
EMBO JOURNAL (2007)
Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches
Jingjing Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The alpha 2 beta 1 integrin: A novel colleetin/C1q receptor
Mary M. Zutter et al.
IMMUNOBIOLOGY (2007)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Diabetes, leukoencephalopathy and rage
Cory Toth et al.
NEUROBIOLOGY OF DISEASE (2006)
Upregulation of RAGE and its ligands in proliferative retinal disease
Sophia I. Pachydaki et al.
EXPERIMENTAL EYE RESEARCH (2006)
LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells
JE Murphy et al.
BIOCHEMICAL JOURNAL (2006)
Calcium-dependent and -independent interactions of the S100 protein family
Liliana Santamaria-Kisiel et al.
BIOCHEMICAL JOURNAL (2006)
High-mobility group box 1 (HMGB1) protein: Friend and foe
Luis Ulloa et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia
E Emanuele et al.
ARCHIVES OF NEUROLOGY (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Involvement of Advanced Glycation End-products (AGEs) in Alzheimer's Disease
Masayoshi Takeuchi et al.
CURRENT ALZHEIMER RESEARCH (2004)
Morphologic findings of coronary atherosclerotic plaques in diabetics - A postmortem study
AP Burke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Drug therapy - Alzheimer's disease
JL Cummings
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding
G Sorci et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The nuclear protein HMGB1 as a proinflammatory mediator
HE Harris et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice
O Arancio et al.
EMBO JOURNAL (2004)
Nε-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease
X Gironés et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)
I Marenholz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo
K Yoshida et al.
CIRCULATION (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Expression and function of C1q receptors and C1q binding proteins at the cell surface
I Ghiran et al.
IMMUNOBIOLOGY (2002)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response
MA Hofmann et al.
GENES AND IMMUNITY (2002)
Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids
K Hayashi et al.
CIRCULATION RESEARCH (2001)
Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion
CH Yeh et al.
DIABETES (2001)
Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy
BI Hudson et al.
DIABETES (2001)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
Share Paper
